Search results
Results from the WOW.Com Content Network
A biogenic amine is a biogenic substance with one or more amine groups. They are basic nitrogenous compounds formed mainly by decarboxylation of amino acids or by amination and transamination of aldehydes and ketones. Biogenic amines are organic bases with low molecular weight and are synthesized by microbial, vegetable and animal metabolisms ...
The enzyme histidine decarboxylase (EC 4.1.1.22, HDC) is transcribed on chromosome 15, region q21.1-21.2, and catalyzes the decarboxylation of histidine to form histamine.In mammals, histamine is an important biogenic amine with regulatory roles in neurotransmission, gastric acid secretion and immune response.
Biogenic amine receptor are a variety of neurotransmitter receptors that are sensitive to biogenic amine neurotransmitters. They mostly belong to the G protein-coupled receptor (GPCR) family of transmembrane receptors , specifically within GPCR "Family A" ( Rhodopsin -like receptors). [ 1 ]
Crude oil, a transformed biogenic substance Natural gum, a secretion from Hevea brasiliensis. A biogenic substance is a product made by or of life forms. While the term originally was specific to metabolite compounds that had toxic effects on other organisms, [1] it has developed to encompass any constituents, secretions, and metabolites of plants or animals. [2]
Activity at an axon terminal: Neuron A is transmitting a signal at the axon terminal to neuron B (receiving). Features: 1. Mitochondrion.2. synaptic vesicle with neurotransmitters.
Trace amines (1 C, 14 P) Pages in category "Biogenic amines" ... Pages in category "Biogenic amines" The following 14 pages are in this category, out of 14 total ...
Trace amines are an endogenous group of trace amine-associated receptor 1 (TAAR1) agonists [1] – and hence, monoaminergic neuromodulators [2] [3] [4] – that are structurally and metabolically related to classical monoamine neurotransmitters. [5] Compared to the classical monoamines, they are present in trace concentrations. [5]
SLC18A2 is essential for enabling the release of neurotransmitters from the axon terminals of monoamine neurons into the synaptic cleft.If SLC18A2 function is inhibited or compromised, monoamine neurotransmitters such as dopamine cannot be released into the synapse via typical release mechanisms (i.e., exocytosis resulting from action potentials).